A previous study reported differences in the peripheral blood counts of CD3+, CD4+, and CD8+ T cells in patients with COVID-19, all of which decreased with increasing disease severity, and also that lymphocyte subset levels were helpful in assessing the disease and determining the prognosis (26). The gene discussed is CD8A; the disease is COVID-19.